ACUTE EFFECTS OF NOVEL PSYCHOACTIVE SUBSTANCES IN CLINICAL PRACTICE: A LITERATURE REVIEW

Novel psychoactive substances (NPS) present a new drug threat emerged on the world stage in the middle 2000s. An increasing number of literature data demonstrate the harmful nature of this class of psychoactive substances.

Mariya V. Prilutskaya 1,2, https://orcid.org/0000-0002-9099-316X

Sergey N. Molchanov 2, https://orcid.org/0000-0002-2568-1581

 

1 Republican Scientific and Practical Center of Mental Health,

Pavlodar city, Kazakhstan;

2 Department of GP and therapy,

Pavlodar branch of Semey State Medical University,

Pavlodar city, Kazakhstan.

1.         Андропова Н.В., Бурлака О.П., Максименко Н.Н. Социально-биологическая и клиническая характеристика лиц, перенесших интоксикационный психоз вследствие употребления синтетических психоактивных веществ // APRIORI. Cерия: Естественные и технические науки. 2015. № 3. С. 3.

2.         Асадуллин А.Р., Юлдашев В.Л., Ахметова Э.А., Халиков С.А. Особенности парентерального употребления метилендиоксипировалерона пациентом с синдромом зависимости от синтетических стимуляторов // Медицинский вестник Башкортостана. 2016. Т. 11. № 4 (64). С. 87-91.

3.         Афанасьев В.В., Баранцевич Е.Р., Пугачева Е.Л. Неврологические нарушения при отравлении спайсами. Что нужно знать врачу «первого контакта»? // Обозрение психиатрии и медицинской психологии им. В.М. Бехтерева. 2016. № 4. С. 92-101.

4.         Афанасьев В.В., Петрова Н.В., Бузанов Д.В., Великова В.Д. Скорая медицинская помощь при отравлении спайсами // Скорая медицинская помощь. 2017. Т. 18. № 1. С. 64-68.

5.         Жевелик О.Д., Работин Р.А., Судаков А.Ю., Шашмурин Д.Н., Ризванова Л.Н., Платонов Е.В. Ретроспективное исследование случаев острой интоксикации синтетическими аналогами наркотических веществ (дизайнерскими наркотиками) в БУ «Нижневартовская психоневрологическая больница» // Здравоохранение Югры: опыт и инновации.  2016. №4. С. 36-44.

6.         Иванова Л.А., Терских Т.В., Тарасенко Т.В., Иванова Л.В. Психотические расстройства у лиц, употребляющих синтетические каннабиноиды (спайсы) // Бюллетень ВСНЦ СЩ РАМНю 2017. № 2(14). С. 14-17.

7.         Иванюженко Н.Д., Волчкова А.Н. Нарушения психики при употреблении курительных смесей // Тюменский медицинский журнал.  2010. № 1. С. 24-25.

8.         Иксанов А.В., Сумная Д.Б., Львовская Е.И. Отравления психодислептиками («солями для ванн» и «спайсами») // Новая наука: Опыт, традиции, инновации. 2016. № 6-2 (89). С. 24-26.

9.         Овчинников А.А., Патрикеева О.Н. Cинтетические каннабиноиды: психотропные эффекты, побочные действия, риски употребления // Journal of Siberian Medical Sciences. 2014. № 3. С. 82.

10.     Остапенко Ю.Н., Белова М.В., Клюев А.Е., Тюрин И.А., Стрельникова Т.А. Острые отравления психоактивными веществами из группы каннабимиметиков. Клиническая картина, диагностика, лечение // Medline.ru. 2015. Т. 16. № 1. С. 176-186.

11.     Раганин М.У., Заттерстрем У, Линдхольм Й. Количественный и качественный химический анализ некурительного табака насвай // Наука и Здравоохранение. 2016. №1. С. 106-119.

12.     Синевич А.А., Копытов А.В.  Анализ психопатологической симптоматики у лиц мужского пола из Республики Беларусь с зависимостью от курительных смесей // Медицинский журнал. 2017. № 1 (59). С. 107-114.

13.     Старченкова А.М., Урсу А.В., Худяков А.В. Клинический случай коморбидности компьютерной игровой зависимости, употребления синтетических каннабиноидов и шизофрении // Вестник Ивановской медицинской академии. 2016. Т. 21. № 4. С. 46-49.

14.     Хорошилов Г.П., Худяков А.В. Интоксикационные психозы, связанные с употреблением современных психоактивных веществ // Практическая медицина. 2015. № 5 (90). С. 7-10.

15.     Чижова Т. Н., Мишкина Е. И., Пилявская О. И., Смагина О. О., Смирнова Т. А. Клинический пример деменции у подростка после комбинированного употребления алкоголя и синтетического наркотического вещества "спайса" //  Материалы Всероссийской междисциплинарной научно-практической конференции «Актуальные проблемы возрастной наркологии и профилактика аддиктивных состояний»,  Челябинск, 14-15 ноября 2013. С. 150-153.

16.     Яцинюк Б.Б., Волкова Н.А., Салманов Ю.М., Фомин И.В. Клиника, диагностика острых отравлений синтетическими каннабиноидами и особенности патогенетической терапии пострадавших // Здравоохранение Югры: опыт и инновации. 2016. № 1 (6). С. 28-44.

17.     Adams A. J., Banister S. D., Irizarry L., Trecki J., Schwartz M., Gerona R. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York // N Engl J Med. 2017.N 376(3). P. 235-242.

18.     Adedinsewo D. A., Oluwaseun O., Todd T. Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion // N Am J Med Sci. 2016. N 8(6). P. 256–258.

19.     Aksel G., Bozan O., Kayaci M., Guneysel O., Sezgin S.B. Rising Threat; Bonsai. // Turk J Emerg Med. 2016. N 15(2). P. 75-78.

20.     Aksel G., Güneysel Ö., Taşyürek T., Kozan E.,  Çevik Ş. E. Intravenous Lipid Emulsion Therapy for Acute Synthetic Cannabinoid Intoxication: Clinical Experience in Four Cases // Case Reports in Emergency Medicine. 2015. V. 2015. P. 5.

21.     Aladağ-Çiftdemir N., Yücel İ., Duran R., Vatansever-Özbek Ü., Acunaş B. A New emerging problem in pediatric emergency units: Synthetic cannabinoids // Turk J Pediatr. 2016. N 58(5). P. 492-497.

22.     Alon M.H., Saint-Fleur M. O. Synthetic cannabinoid induced acute respiratory depression: Case series and literature review // Respir Med Case Rep. 2017. N 22. P. 137-141.

23.     Andreasen M. F., Telving R., Rosendal I., Eg M. B., Hasselstrøm J. B., Andersen L. V. A fatal poisoning involving 25C-NBOMe // Forensic Sci Int. 2015.N 251. e1-8.

24.     Arora A., Kumar A., Raza M. N. 'Legal high' associated Wallenberg syndrome. // BMJ Case Rep. 2013. 2013. bcr2013009693.

25.     Assi S., Gulyamova N., Ibrahim K., Kneller P., Osselton D. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies  // Hum Psychopharmacol. 2017. N. 32(3) - e2607.

26.     Atik S. U., Dedeoğlu R., Varol F., Çam H., Eroğlu A. G., Saltık L. Cardiovascular side effects related with use of synthetic cannabinoids “bonzai” : two case reports // Turk Pediatri Ars. 2015. N 50(1). P. 61–64.

27.     Aygün A., Katipoğlu B., İmamoğlu M., Kılıç  M., Karapolat  B. S., Türkyılmaz  A. Acute Respiratory Distress Syndrome and Pneumothorax after Synthetic Cannabinoid Intoxication // Eurasian Journal Of Case Report Emergency Medicine.  2017.  N 16. P. 86-87.

28.     Bäckberg M., Tworek L., Beck O., Helander A. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project // J Med Toxicol. 2017. N 13(1). P. 52-60.

29.     Barceló B., Pichini S, López-Corominas V., Gomila I., Yates C., Busardò F. P., Pellegrini M. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series // Forensic Sci Int. 2017. N 273. e10 - e14.

30.     Bayrakdar R., Basturk T., Koc Y. , Sakaci T., Ahbap E., Kara E. Synthetic cannabinoid induced acute kidney injury in two previously healthy young men //  Medica Case Study.   2015. V. 6. N 1. P. 1-4. 

31.     Behonick G., Shanks K. G., Firchau D. J., Mathur G., Lynch C. F., Nashelsky M., Jaskierny D. J., Meroueh C. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22 // J Anal Toxicol. 2014. N 38(8). P. 559-562.

32.     Berkowitz E. A., Henry T. S., Veeraraghavan S., Staton G. W. Jr., Gal A. A. Pulmonary effects of synthetic marijuana: chest radiography and CT findings // Am J Roentgenol. 2015.  N 204(4). P. 750-757.

33.     Buyukbese S. S. Unusual side effect of cannabis use: acute abdomen due to duodenal perforation // Int J Emerg Med. 2016. N 9(1). P. 18.

34.     Chan W. L., Wood D. M., Hudson S., Dargan P. I. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl) benzofuran (6-APB) and cannabis. // J Med Toxicol. 2013.  N 9(3). P. 278-281.

35.     Chapman M. H., M. Kajihara, G. Borges, J. O’Beirne, Patch D., Dhillon A. P., Crozier A., Morgan M. Y. Severe, Acute Liver Injury and Khat Leaves // Engl J Med. 2010. N 362. P. 17.

36.     Coopman V., Blanckaert P., Van Parys G., Van Calenbergh S., Cordonnier J.  A case of acute intoxication due to combined use of fentanyl and 3,4-dichloro-N-[2(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) // Forensic Sci Int. 2016. N 266. P. 68-72.

37.     Cole J. B., Dunbar J. F., McIntire S. A., Regelmann W. E., Slusher T. M. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhag // Pediatrics. 2015.  N 3. e740-743.

38.     Crespi C. Flakka-Induced Prolonged Psychosis // Case Reports in Psychiatry. 2016. V. 2016. P. 2.

39.     Dean S. A., Jufer-Phipps R., Fowler D.R., Kutys R., Ladich E., Alexander R.  Acute Coronary Artery Thrombosis Associated with Synthetic Cannabinoid Intoxication // Academic Forensic Pathology: The Official Publication Of The National Association Of Medical Examiners. 2016. P. 127-132.

40.     de Havenon A., Chin B., Thomas K.C., Afra P. The secret "spice": an undetectable toxic cause of seizure // Neurohospitalist. 2011. N 1(4). P. 182-186.

41.     Demirci H., Coşar R., Çiftçi Ö., Sarı I.K. Atypical diabetic ketoacidosis: case report // Balkan Med J. 2015.  N 32(1). P. 124-126.

42.     Efe T. H., Felekoglu M. A., Çimen T., Doğan M.  Atrial fibrillation following synthetic cannabinoid abuse // Turk Kardiyol Dern Ars.  2017. N 45(4). P. 362-364.

43.     Ergül D. F., Ekemen S., Yelken B. B. Synthetic Cannabinoid 'Bonzai' Intoxication: Six Case Series // Turk J Anaesthesiol Reanim. 2015. N 43(5). P. 347-351.

44.     European Monitoring Centre for Drugs and Drug (EMCDDA) Addiction Risk assessment of new psychoactive substances. Operating guidelines. Luxembourg. 2010. P. 21-33.

45.     Fels H., Krueger J., Sachs H., Musshoff F., Graw M., Roider G., Stoever A. Two fatalities associated with synthetic opioids: AH-7921 and MT-45 // Forensic Sci Int. 2017. N 277. e30-e35.

46.     Guerrieri D., Rapp E., Roman M., Thelander G., Kronstrand R. Acrylfentanyl: Another new psychoactive drug with fatal consequences // Forensic Sci Int. 2017. N 277. e21-e29

47.     Gunderson E. W., Haughey H. M., Ait-Daoud N., Joshi A. S., Hart C. L. A survey of synthetic cannabinoid consumption by current cannabis users // Subst Abus. 2014 . N 35(2). P. 184-189.

48.     Haq E. U., Shafiq A., Khan A. A., Awan A. A., Ezad S., Minteer W. J., Omar B. "Spice" (Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series //  Case Rep Cardiol. 2017. V. 2017. P. 9252463.

49.     Heath T. S., Burroughs Z., Thompson A. J., Tecklenburg F. W. Acute intoxication caused by a synthetic cannabinoid in two adolescents // J Pediatr Pharmacol Ther. 2012. N 17(2). P. 177-181.

50.     Hess C., Stockhausen S., Kernbach-Wighton G., Madea B. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids? // Forensic Sci Int. 2015.  N 257. e 6-11.

51.     Humston C., Miketic R., Moon K., Ma P., Tobia J.  Toxic Leukoencephalopathy in a Teenager Caused by the Recreational Ingestion of 25I-NBOMe: A Case Report and Review of Literature // J Med Cases. 2017. N 8(6). P. 174-179.

52.     Ibrahim S., Al-Saffar F., Wannenburg T. A. Unique Case of Cardiac Arrest following K2 Abuse // Case Reports in Cardiology. V. 2014. P. 3.

53.     Johansson A., Lindstedt D., Gunill M. R.,  Thelander E., Lennborn N., Sandlerde H.,  Rubertsson S., Ahlnera J., Kronstrand R.,  Kugelberg F. C.  A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP // Forensic Science International. 2017. V 275. P. 76-82.

54.     Karass M., Chugh S., Andries G., Mamorska-Dyga A., Nelson J. C., Chander P. N. Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists // Stem Cell Investig. 2017. N 4. P. 43.

55.     Katz K. D., Leonetti A. L., Bailey B.C., Surmaitis R. M., Eustice E.R., Kacinko S., Wheatley S.M. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center // West J Emerg Med. 2016. N 17(3). P. 290-294.

56.     Kazory A., Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association // Clin Kidney J. 2013. N 6(3). P. 330-333.

57.     Khan S., Shaheen F.,  Sarwar H., Molina J., Mushtaq S. “Bath Salts”–Induced Psychosis in a Young Woman // Prim Care Companion CNS Disor. 2013. N 15(1). PCC.12l01417.

58.     Kolli V., Sharma A., Amani M., Bestha D., Chaturvedi R. “Meow Meow” (Mephedrone) and Catatonia // Innov Clin Neurosci. 2013. N 10(2). P. 11–12.

59.     Kulhawik D., Walecki J. Toxic lung injury in a patient addicted to "legal highs" - case study // Pol J Radiol. 2015. N 80. P. 62-66.

60.     Labay L. M., Caruso J. L., Gilson T. P., Phipps R. J., Knight L. D., Lemos N.P., McIntyre I. M., Stoppacher R., Tormos L. M., Wiens A. L., Williams E., Logan B. K. Synthetic cannabinoid drug use as a cause or contributory cause of death // Forensic Sci Int. 2016. N 260. P. 31-39.

61.     Lee D., Chronister C.W., Hoyer J., Goldberger B.A. Ethylone-Related Deaths: Toxicological Findings // J Anal Toxicol. 2015. N 39(7). P. 567-571.

62.     Lowe L. M., Peterson B. L., Couper F. J. A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State // J Anal Toxicol. 2015. N 39(8). P. 668- 671.

63.     Macfarlane V., Christie G. Synthetic cannabinoid withdrawal: a new demand on detoxification services // Drug Alcohol Rev. 2015. N 34(2). P. 147-153.

64.     Martin A. Aspects of Substance Displacement - From Illicit Drugs to Novel Psychoactive Substances // J Addict Res Ther. 2016. N 7. P. 283.

65.     Maskell P. D., De Paoli G., Seneviratne C., Pounder D. J. Mephedrone (4-Methylmethcathinone)-Related Deaths // Journal of Analytical Toxicology. 2011.  V.  35.  N 3. P. 188–191.

66.     McIlroy G., Ford L., Khan J. M.  Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report // BMC Pharmacol Toxicol. 2016. N 17. P. 2.

67.     McIntyre I. M., Trochta A., Gary R. D., Malamatos M., Lucas J. R. An Acute Acetyl Fentanyl Fatality: A Case Report With Postmortem Concentrations // J Anal Toxicol. 2015. V. 39. N 6. P. 490-494.

68.     McKeever R.G., Vearrier D., Jacobs D., LaSala G., Okaneku J., Greenberg M. I. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report // J Med Toxicol. 2015.  N 11(1). P. 129-131.

69.     Moeller S., Lücke C., Struffert T., Schwarze B., Gerner S.T., Schwab S., Köhrmann M.,  Machold K., Philipsen A., Müller H. H. Ischemic stroke associated with the use of a synthetic cannabinoid (spice) // Asian J Psychiatr. 2017.  N 25. P. 127-130.

70.     O'Connor A. D., Padilla-Jones A., Gerkin R. D., Levine M. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants. // J Med Toxicol. 2015. N 11(2). P. 195-200.

71.     Orsini J., Blaak C., Tam E., Rajayer S., Morante J., Yeh A., Butala A. The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity. // Case Rep Crit Care. 2015. 542490.

72.     Papanti D., Schifano F., Botteon G., Bertossi F., Mannix J., Vidoni D., Impagnatiello M., Pascolo-Fabrici E., Bonavigo T.  "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report //  Hum Psychopharmacol. 2013. N28(4). P. 379-389.

73.     Puha G., Lionte C., Bologa C., Sorodoc L.  An unusual cause of myocardial ischemia in young adults // Romanian Journal of Cardiology. 2016. V. 26. N 4. P. 471-475.

74.     Ray W. Z., Krisht K. M., Schabel A., Schmidt R. H. Subarachnoid hemorrhage from a thoracic radicular artery pseudoaneurysm after methamphetamine and synthetic cannabinoid abuse: case report // Global Spine J. 2013. N 3(2). P. 119-124.

75.     Raythatha, Avani B. S., Shah A., Tucci V.,  Moukaddam N. Synthetic Cannabinoids and Dysphonia: A Case Report // J Gen Practice. 2016. N  4. P. 1. 

76.     Redfern A., Sampson C., Giovannelli M.   Acute cardiomyopathy with MCAT abuse  // Journal of the Intensive Care Society. 2015.  V. 16. N 1. P. 83–84.

77.     Riederer A. M., Campleman S. L., Carlson R. G., Boyer E. W., Manini A. F., Wax P. M., Brent J. A. Toxicology Investigators Consortium (ToxIC). Toxicology Investigators Consortium Registry Sites, 2010-2015. Acute Poisonings from Synthetic Cannabinoids - 50 U.S.  // MMWR Morb Mortal Wkly Rep. 2016. N 65(27). P. 692-695.

78.     Roberto A. J., Lorenzo A., Li K. J., Young J., Mohan A., Pinnaka S., Lapidus K. First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone // A. Case Rep Psychiatry. 2016. 7257489.

79.     Rose D.Z., Guerrero W.R., Mokin M.V., Gooch C. L., Bozeman A.C., Pearson J.M., Burgin W.S. Hemorrhagic stroke following use of the synthetic marijuana "spice" // Neurology. 2015. N 85(13). P. 1177-1179.

80.     Samaan J., Ferrer G. F., Akinyemi B., Junquera P.,  Oms J., Dumenigo R. Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature // Case Reports in Psychiatry. 2016. V. 2016. P. 7.

81.     Sethi R., Thapa N., Saxena A., Chahil R. "K2/Spice": have you updated your differentials? A case report // Prim Care Companion CNS Disord. 2013. N 15(2). pii: PCC.12l01402.

82.     Shanks K. G., Clark W., Behonick G. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA. // J Anal Toxicol. 2016. N 40(3). P. 236-239.

83.     Shanks K. G., Dahn T., Terrell A. R. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework // J Anal Toxicol. 2012. N 36(3). P. 145-152.

84.     Sharma T. R., Iskandar J. W., Ali R., Shah U. R. Bath salts-induced delirium and brief psychotic episode in an otherwise healthy young man // Prim Care Companion CNS Disord. 2012. N 14(2). pii: PCC.11l01224.

85.     Sheikh I. A., Lukšič M., Ferstenberg R., Culpepper-Morgan J. A. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine // Am J Case Rep. 2014 Dec 30;15:584-8.

86.     Sivagnanam K., Chaudari  D., Lopez P.,  Sutherland M. E., Ramu  V. K. “Bath salts” induced severe reversible cardiomyopathy // Am J Case Rep. 2013. N 14. P. 288–291.

87.     Sönmez I., Köşger  F. Psychotic Disorder Associated With Synthetic Cannabinoid Receptor Agonist: a Case Report  //  Turkish Journal of Psychiatry.  2014.  N 2014. P.1-2.

88.     Srisung W., Jamal F., Prabhakar S. Synthetic cannabinoids and acute kidney injury // Proc (Bayl Univ Med Cent. 2015. N 28(4). P. 475-477.

89.     Streur W. J., Hurlburt W. B., McLaughlin J., Castrodale L. Psychoactive “Bath Salts” Toxicity in Alaska—A Case Series //  State of Alaska Epidemioilogy Bulletin. 2011. N 27. URL: http://www.epi.hss.state.ak.us/bulletins/docs/b2011_27.pdf - (дата обращения: 03.02.2018).

90.     Truscott S. M., Crittenden N. E., Shaw M. A., Middleberg R. A., Jortani S. A. Violent Behavior and Hallucination in a 32-Year-Old Patient // Clinical Chemistry. V. 59. N 4. P. 612-614.

91.     Ukaigwe A., Karmacharya P., Donato A. A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid // Case Rep Emerg Med. 2014. 167098.

92.     United Nations Office on Drugs and Crime (UNODC) Central Asia Synthetic Drugs Situation Assessment - A Report from the UNODC Global SMART Programme Vienna.  December 2017 – P.22-24 – URL: http://www.unodc.org/documents/scientific/Central_Asia_November_2017_FINAL.pdf - (дата обращения: 03.02.2018).

93.     Vallersnes O. M., Dines A. M., Wood D. M., Yates C., Heyerdahl F., Hovda K. E., Giraudon I. Euro-DEN Research Group, Dargan P. I. Psychosis associated with acute recreational drug toxicity: a European case series // BMC Psychiatry. 2016.  N 16. P. 293.

94.     Van Amsterdam J., Brunt T., van den Brink W. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects //  J Psychopharmacol. 2015. N 29. P. 254–263.

95.     Vorce S. P., Knittel J. L., Holler J. M., Magluilo J. Jr., Levine B., Berran P., Bosy T. Z. A fatality involving AH-7921 // J Anal Toxicol. 2014. N 38(4). P. 226-230.

96.     Wyman J. F., Lavins E. S., Engelhart D., Armstrong E. J., Snell K. D., Boggs P. D., Taylor S. M., Norris R. N., Miller F. P. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts" // J Anal Toxicol. 2013.  N 37(3). N 182-185.

97.     Yasuhisa Y. F., Koeda F. A., Inoue Y. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones  // Acute Medicine and Surgery. 2016. V. 3. N. 3. P. 230–236.  

98.     Yazici A.B., Yazici E., Erol  A.   Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid Withdrawal // Case Reports in Medicine. 2017. V. 2017. P 6.

99.     Zhao A., Tan M., Maung A., Salifu M., Mallappallil M. Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids // Case Reports in Nephrology. V. 2015. P. 4.

References:

1.         Andropova N.V., Burlaka O.P., Maksimenko N.N. Sotsial'no-biologicheskaya i klinicheskaya kharakteristika lits, perenesshikh intoksikatsionnyi psikhoz vsledstvie upotrebleniya sinteticheskikh psikhoaktivnykh veshhestv [Social, biological and clinical characteristics of persons experienced intoxicational psychosis due to use of novel psychoactive substances]. APRIORI. Ceriya: Estestvennye i tekhnicheskie nauki. [Part: Natural and technical science] 2015. 3. pp. 3 [in Russian].

2.         Asadullin A.R., Juldashev V.L., Ahmetova Je.A., Halikov S.A. Osobennosti parenteral'nogo upotrebleniya metilendioksipirovalerona patsientom s sindromom zavisimosti ot sinteticheskikh stimulyatorov [Features of parenteral use of methyldioxipyrovalerone of patients with dependence syndrome caused by synthetic sstimulators]. Meditsinskii vestnik Bashkortostana [Medical bulletin of Bashkortostan]. 2016. 11. 4 (64). pp. 87-91 [in Russian].

3.         Afanas'ev V.V., Barancevich E.R., Pugacheva E.L. Nevrologicheskie narusheniya pri otravlenii spaisami. Chto nuzhno znat' vrachu «pervogo kontakta»? [Neurological failures caused by spice intoxication. What should know the doctor of the firs contact?]. Obozrenie psikhiatrii i meditsinskoi psikhologii im. V.M. Bekhtereva [Survey of psychiatry and medical psychology named after VM. Bechtev]. 2016. 4. pp. 92-101 [in Russian].

4.         Afanas'ev V.V., Petrova N.V., Buzanov D.V., Velikova V.D. Skoraya meditsinskaya pomoshh' pri otravlenii spaisami [Emergency medical care for spicy poisoning]. Skoraya meditsinskaya pomoshch [Emergency medical care]. 2017. 18. 1. pp. 64-68 [in Russian].

5.         Zhevelik O.D., Rabotin R.A., Sudakov A.Ju., Shashmurin D.N., Rizvanova L.N., Platonov E.V. Retrospektivnoe issledovanie sluchaev ostroi intoksikatsii sinteticheskimi analogami narkoticheskikh veshhestv (dizainerskimi narkotikami) v BU «Nizhnevartovskaya psikhonevrologicheskaya bol'nitsa» [A retrospective study of cases of acute intoxication with synthetic analogues of narcotic substances (designer drugs) in Nizhnevartovsk psychoneurological hospital]. Zdravookhranenie Yugry: opyt i innovatsii [Healthсare of Ugra: experience and innovations]. 2016. 4. pp. 36-44 [in Russian].

6.         Ivanova L.A., Terskih T.V., Tarasenko T.V., Ivanova L.V.  Psikhoticheskie rasstroistva u lits, upotreblyayushhikh sinteticheskie kannabinoidy (spaisy) [Psychotic disorders in individuals who use synthetic cannabinoids (spices)]. Bjulleten' VSNC SShh RAMNyu [Bulletin of the East Siberian Scientific Center of the Russian Academy of Sciences]. 2017. 2(14). pp. 14-17 [in Russian].

7.         Ivanyuzhenko N.D., Volchkova A.N. Narusheniya psikhiki pri upotreblenii kuritel'nykh smesei [Psychic disturbance due to use of smoking mixtures]. Tyumenskii meditsinskii zhurnal [Tyumen Medical Journal]. 2010. 1. pp. 24-25 [in Russian].

8.         Iksanov A.V., Sumnaya D.B., L'vovskaya E.I. Otravleniya psikhodisleptikami («solyami dlya vann» i «spaisami») [Intoxication cause by dysleptics (“bath salts” and “spices”)]. Novaya nauka: Opyt, traditsii, innovatsii [New science: Experience, traditions, innovations]. 2016. 6-2 (89). pp. 24-26 [in Russian].

9.         Ovchinnikov A.A., Patrikeeva O.N. Cinteticheskie kannabinoidy: psikhotropnye effekty, pobochnye dejstvija, riski upotreblenija [Synthetic cannabinoids: psychotropic effects, side effects, risks of consumption]. Journal of Siberian Medical Sciences. 2014. 3. pp. 82 [in Russian].

10.     Ostapenko Ju.N., Belova M.V., Klyuev A.E., Tyurin I.A., Strel'nikova T.A. Ostrye otravleniya psikhoaktivnymi veshhestvami iz gruppy kannabimimetikov. Klinicheskaya kartina, diagnostika, lechenie [Acute poisoning caused by psychoactive substances from the group of cannabimimetics. Clinical picture, diagnosis, treatment]. Medline.ru. 2015. 16. 1. pp. 176-186 [in Russian].

11.     Raganin M.U., Zätterström U., Lindholm J. Kolichestvennyi i kachestvennyi khimicheskii analiz nekuritel'nogo tabaka nasvai [Quantitative and qualitative chemical analysis of smokeless tobacco nasvay]. Nauka i Zdravookhranenie [Science & Healthcare]. 2016, 1, pp. 106-119.

12.     Sinevich A.A., Kopytov A.V. Analiz psikhopatologicheskoi simptomatiki u lits muzhskogo pola iz Respubliki Belarus' s zavisimost'yu ot kuritel'nykh smesei [Analysis of psychopathological symptoms in males from the Republic of Belarus with dependence on smoking mixtures]. Meditsinskii zhurnal [Medical Journal].  2017. 1 (59). pp. 107-114 [in Russian].

13.     Starchenkova A.M., Ursu A.V., Hudyakov A.V. Klinicheskii sluchai komorbidnosti komp'yuternoi igrovoi zavisimosti, upotrebleniya sinteticheskikh kannabinoidov i shizofrenii [The clinical case of comorbidity of computer game dependence, the use of synthetic cannabinoids and schizophrenia]. Vestnik Ivanovskoi meditsinskoi akademii [Bulletin of the Ivanovo Medical Academy]. 2016. 21. 4. pp. 46-49 [in Russian].

14.     Horoshilov G.P., Hudyakov A.V. Intoksikatsionnye psikhozy, svyazannye s upotrebleniem sovremennykh psikhoaktivnykh veshhestv [Intoxication psychoses associated with the use of modern psychoactive substances]. Prakticheskaya meditsina [Practical Medicine]. 2015. 5 (90). pp. 7-10 [in Russian].

15.     Chizhova T. N., Mishkina E. I., Piljavskaja O. I., Smagina O. O., Smirnova T. A. Klinicheskii primer dementsii u podrostka posle kombinirovannogo upotrebleniya alkogolya i sinteticheskogo narkoticheskogo veshhestva "spaisa" [A clinical example of dementia in adolescents after combined use of alcohol and synthetic drug "spice"]. Materialy Vserossiiskoi mezhdistsiplinarnoi nauchno-prakticheskoi konferentsii «Aktual'nye problemy vozrastnoi narkologii i profilaktika addiktivnykh sostoyanii» [Materials of the All-Russia interdisciplinary scientific and practical conference "Actual problems of age-related narcology and prevention of addictive states"]. Chelyabinsk, 14-15 November 2013. pp. 150-153 [in Russian].

16.     Yatsinyuk B.B., Volkova N.A., Salmanov Yu.M., Fomin I.V. Klinika, diagnostika ostrykh otravlenii sinteticheskimi kannabinoidami i osobennosti patogeneticheskoi terapii postradavshikh [Clinic, diagnostics of acute poisoning with synthetic cannabinoids and features of its pathogenetic therapy].  Zdravookhranenie Yugry: opyt i innovatsii [Healthсare of Ugra: experience and innovations]. 2016. 1 (6). pp. 28-44 [in Russian].

17.     Adams A. J., Banister S. D., Irizarry L., Trecki J., Schwartz M., Gerona R. "Zombie" Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York. N Engl J Med. 2017.N 376(3). P. 235-242.

18.     Adedinsewo D. A., Oluwaseun O., Todd T. Acute Rhabdomyolysis Following Synthetic Cannabinoid Ingestion. N Am J Med Sci. 2016. N 8(6). P. 256–258.

19.     Aksel G., Bozan O., Kayaci M., Guneysel O., Sezgin S.B. Rising Threat; Bonsai. Turk J Emerg Med. 2016. N 15(2). P. 75-78.

20.     Aksel G., Güneysel Ö., Taşyürek T., Kozan E., Çevik Ş. E. Intravenous Lipid Emulsion Therapy for Acute Synthetic Cannabinoid Intoxication: Clinical Experience in Four Cases. Case Reports in Emergency Medicine. 2015. V. 2015. P. 5.

21.     Aladağ-Çiftdemir N., Yücel İ., Duran R., Vatansever-Özbek Ü., Acunaş B. A New emerging problem in pediatric emergency units: Synthetic cannabinoids. Turk J Pediatr. 2016. N 58(5). P. 492-497.

22.     Alon M.H., Saint-Fleur M. O. Synthetic cannabinoid induced acute respiratory depression: Case series and literature review. Respir Med Case Rep. 2017. N 22. P. 137-141.

23.     Andreasen M. F., Telving R., Rosendal I., Eg M. B., Hasselstrøm J. B., Andersen L. V. A fatal poisoning involving 25C-NBOMe. Forensic Sci Int. 2015.N 251. e1-8.

24.     Arora A., Kumar A., Raza M. N. 'Legal high' associated Wallenberg syndrome. BMJ Case Rep. 2013. 2013. bcr2013009693.

25.     Assi S., Gulyamova N., Ibrahim K., Kneller P., Osselton D. Profile, effects, and toxicity of novel psychoactive substances: A systematic review of quantitative studies. Hum Psychopharmacol. 2017. N. 32(3) - e2607.

26.     Atik S. U., Dedeoğlu R., Varol F., Çam H., Eroğlu A. G., Saltık L. Cardiovascular side effects related with use of synthetic cannabinoids “bonzai” : two case reports . Turk Pediatri Ars. 2015. N 50(1). P. 61–64.

27.     Aygün A., Katipoğlu B., İmamoğlu M., Kılıç  M., Karapolat  B. S., Türkyılmaz  A. Acute Respiratory Distress Syndrome and Pneumothorax after Synthetic Cannabinoid Intoxication. Eurasian Journal Of Case Report Emergency Medicine.  2017.  N 16. P. 86-87.

28.     Bäckberg M., Tworek L., Beck O., Helander A. Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project.  J Med Toxicol. 2017. N 13(1). P. 52-60.

29.     Barceló B., Pichini S, López-Corominas V., Gomila I., Yates C., Busardò F. P., Pellegrini M. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series. Forensic Sci Int. 2017. N 273. e10 - e14.

30.     Bayrakdar R., Basturk T., Koc Y., Sakaci T., Ahbap E., Kara E. Synthetic cannabinoid induced acute kidney injury in two previously healthy young men. Medica Case Study.   2015. V. 6. N 1. P. 1-4. 

31.     Behonick G., Shanks K. G., Firchau D. J., Mathur G., Lynch C. F., Nashelsky M., Jaskierny D. J., Meroueh C. Four postmortem case reports with quantitative detection of the synthetic cannabinoid, 5F-PB-22. J Anal Toxicol. 2014. N 38(8). P. 559-562.

32.     Berkowitz E. A., Henry T. S., Veeraraghavan S., Staton G. W. Jr., Gal A. A. Pulmonary effects of synthetic marijuana: chest radiography and CT findings. Am J Roentgenol. 2015.  N 204(4). P. 750-757.

33.     Buyukbese S. S. Unusual side effect of cannabis use: acute abdomen due to duodenal perforation. Int J Emerg Med. 2016. N 9(1). P. 18.

34.     Chan W. L., Wood D. M., Hudson S., Dargan P. I. Acute psychosis associated with recreational use of benzofuran 6-(2-aminopropyl) benzofuran (6-APB) and cannabis. J Med Toxicol. 2013.  N 9(3). P. 278-281.

35.     Chapman M. H., M. Kajihara, G. Borges, J. O’Beirne, Patch D., Dhillon A. P., Crozier A., Morgan M. Y. Severe, Acute Liver Injury and Khat Leaves. Engl J Med. 2010. N 362. P. 17.

36.     Coopman V., Blanckaert P., Van Parys G., Van Calenbergh S., Cordonnier J. A case of acute intoxication due to combined use of fentanyl and 3,4 – dichloro – N - [2 (dimethylamino) cyclohexyl] – N - methylbenzamide (U-47700). Forensic Sci Int. 2016. N 266. P. 68-72.

37.     Cole J. B., Dunbar J. F., McIntire S. A., Regelmann W. E., Slusher T. M. Butyrfentanyl overdose resulting in diffuse alveolar hemorrhag. Pediatrics. 2015.  N 3. e740-743.

38.     Crespi C. Flakka-Induced Prolonged Psychosis. Case Reports in Psychiatry. 2016. V. 2016. P. 2.

39.     Dean S. A., Jufer-Phipps R., Fowler D.R., Kutys R., Ladich E., Alexander R.  Acute Coronary Artery Thrombosis Associated with Synthetic Cannabinoid Intoxication. Academic Forensic Pathology: The Official Publication Of The National Association Of Medical Examiners. 2016. P. 127-132.

40.     de Havenon A., Chin B., Thomas K.C., Afra P. The secret "spice": an undetectable toxic cause of seizure. Neurohospitalist. 2011. N 1(4). P. 182-186.

41.     Demirci H., Coşar R., Çiftçi Ö., Sarı I.K. Atypical diabetic ketoacidosis: case report.  Balkan Med J. 2015.  N 32(1). P. 124-126.

42.     Efe T. H., Felekoglu M. A., Çimen T., Doğan M.  Atrial fibrillation following synthetic cannabinoid abuse. Turk Kardiyol Dern Ars. 2017. N 45(4). P. 362-364.

43.     Ergül D. F., Ekemen S., Yelken B. B. Synthetic Cannabinoid 'Bonzai' Intoxication: Six Case Series. Turk J Anaesthesiol Reanim. 2015. N 43(5). P. 347-351.

44.     European Monitoring Centre for Drugs and Drug (EMCDDA) Addiction Risk assessment of new psychoactive substances. Operating guidelines. Luxembourg. 2010. P. 21-33.

45.     Fels H., Krueger J., Sachs H., Musshoff F., Graw M., Roider G., Stoever A. Two fatalities associated with synthetic opioids: AH-7921 and MT-45. Forensic Sci Int. 2017. N 277. e30-e35.

46.     Guerrieri D., Rapp E., Roman M., Thelander G., Kronstrand R.  Acrylfentanyl: Another new psychoactive drug with fatal consequences. Forensic Sci Int. 2017. N 277. e21-e29

47.     Gunderson E. W., Haughey H. M., Ait-Daoud N., Joshi A. S., Hart C. L. A survey of synthetic cannabinoid consumption by current cannabis users. Subst Abus. 2014 . N 35(2). P. 184-189.

48.     Haq E. U., Shafiq A., Khan A. A., Awan A. A., Ezad S., Minteer W. J., Omar B. "Spice" (Synthetic Marijuana) Induced Acute Myocardial Infarction: A Case Series. Case Rep Cardiol. 2017. V. 2017. P. 9252463.

49.     Heath T. S., Burroughs Z., Thompson A. J., Tecklenburg F. W. Acute intoxication caused by a synthetic cannabinoid in two adolescents. J Pediatr Pharmacol Ther. 2012. N 17(2). P. 177-181.

50.     Hess C., Stockhausen S., Kernbach-Wighton G., Madea B. Death due to diabetic ketoacidosis: Induction by the consumption of synthetic cannabinoids? Forensic Sci Int. 2015.  N 257. e 6-11.

51.     Humston C., Miketic R., Moon K., Ma P., Tobia J. Toxic Leukoencephalopathy in a Teenager Caused by the Recreational Ingestion of 25I-NBOMe: A Case Report and Review of Literature. J Med Cases. 2017. N 8(6). P. 174-179.

52.     Ibrahim S., Al-Saffar F., Wannenburg T. A. Unique Case of Cardiac Arrest following K2 Abuse. Case Reports in Cardiology. V. 2014. P. 3.

53.     Johansson A., Lindstedt D., Gunill M. R., Thelander E., Lennborn N., Sandlerde H., Rubertsson S., Ahlnera J., Kronstrand R., Kugelberg F. C. A non-fatal intoxication and seven deaths involving the dissociative drug 3-MeO-PCP. Forensic Science International. 2017. V 275. P. 76-82.

54.     Karass M., Chugh S., Andries G., Mamorska-Dyga A., Nelson J. C., Chander P. N. Thrombotic microangiopathy associated with synthetic cannabinoid receptor agonists. Stem Cell Investig. 2017. N 4. P. 43.

55.     Katz K.D., Leonetti A.L., Bailey B.C., Surmaitis R.M., Eustice E.R., Kacinko S., Wheatley S.M. Case Series of Synthetic Cannabinoid Intoxication from One Toxicology Center. West J Emerg Med. 2016. N 17(3). P. 290-294.

56.     Kazory A., Aiyer R. Synthetic marijuana and acute kidney injury: an unforeseen association. Clin Kidney J. 2013. N 6(3). P. 330-333.

57.     Khan S., Shaheen F.,  Sarwar H., Molina J., Mushtaq S. “Bath Salts”–Induced Psychosis in a Young Woman. Prim Care Companion CNS Disor. 2013. N 15(1). PCC.12l01417.

58.     Kolli V., Sharma A., Amani M., Bestha D., Chaturvedi R. “Meow Meow” (Mephedrone) and Catatonia. Innov Clin Neurosci. 2013. N 10(2). P. 11–12.

59.     Kulhawik D., Walecki J. Toxic lung injury in a patient addicted to "legal highs" - case study. Pol J Radiol. 2015. N 80. P. 62-66.

60.     Labay L. M., Caruso J. L., Gilson T. P., Phipps R. J., Knight L. D., Lemos N.P., McIntyre I. M., Stoppacher R., Tormos L. M., Wiens A. L., Williams E., Logan B. K. Synthetic cannabinoid drug use as a cause or contributory cause of death. Forensic Sci Int. 2016. N 260. P. 31-39.

61.     Lee D., Chronister C.W., Hoyer J., Goldberger B.A. Ethylone-Related Deaths: Toxicological Findings. J Anal Toxicol. 2015. N 39(7). P. 567-571.

62.     Lowe L. M., Peterson B. L., Couper F. J. A Case Review of the First Analytically Confirmed 25I-NBOMe-Related Death in Washington State. J Anal Toxicol. 2015. N 39(8). P. 668- 671.

63.     Macfarlane V., Christie G. Synthetic cannabinoid withdrawal: a new demand on detoxification services. Drug Alcohol Rev. 2015. N 34(2). P. 147-153.

64.     Martin A. Aspects of Substance Displacement - From Illicit Drugs to Novel Psychoactive Substances. J Addict Res Ther. 2016. N 7. P. 283.

65.     Maskell P.D., De Paoli G., Seneviratne C., Pounder D.J. Mephedrone (4-Methylmethcathinone) - Related Deaths. Journal of Analytical Toxicology. 2011. V. 35. N 3. P. 188–191.

66.     McIlroy G., Ford L., Khan J. M.  Acute myocardial infarction, associated with the use of a synthetic adamantyl-cannabinoid: a case report. BMC Pharmacol Toxicol. 2016. N 17. P. 2.

67.     McIntyre I.M., Trochta A., Gary R. D., Malamatos M., Lucas J. R. An Acute Acetyl Fentanyl Fatality: A Case Report With Postmortem Concentrations. J Anal Toxicol. 2015. V. 39. N 6. P. 490-494.

68.     McKeever R.G., Vearrier D., Jacobs D., LaSala G., Okaneku J., Greenberg M. I. K2--not the spice of life; synthetic cannabinoids and ST elevation myocardial infarction: a case report. J Med Toxicol. 2015.  N 11(1). P. 129-131.

69.     Moeller S., Lücke C., Struffert T., Schwarze B., Gerner S.T., Schwab S., Köhrmann M., Machold K., Philipsen A., Müller H. H. Ischemic stroke associated with the use of a synthetic cannabinoid (spice). Asian J Psychiatr. 2017.  N 25. P. 127-130.

70.     O'Connor A. D., Padilla-Jones A., Gerkin R. D., Levine M. Prevalence of Rhabdomyolysis in Sympathomimetic Toxicity: a Comparison of Stimulants. J Med Toxicol. 2015. N 11(2). P. 195-200.

71.     Orsini J., Blaak C., Tam E., Rajayer S., Morante J., Yeh A., Butala A. The Wide and Unpredictable Scope of Synthetic Cannabinoids Toxicity. Case Rep Crit Care. 2015. 542490.

72.     Papanti D., Schifano F., Botteon G., Bertossi F., Mannix J., Vidoni D., Impagnatiello M., Pascolo-Fabrici E., Bonavigo T.  "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report. Hum Psychopharmacol. 2013. N28(4). P. 379-389.

73.     Puha G., Lionte C., Bologa C., Sorodoc L.  An unusual cause of myocardial ischemia in young adults. Romanian Journal of Cardiology. 2016. V. 26. N 4. P. 471-475.

74.     Ray W. Z., Krisht K. M., Schabel A., Schmidt R. H. Subarachnoid hemorrhage from a thoracic radicular artery pseudoaneurysm after methamphetamine and synthetic cannabinoid abuse: case report. Global Spine J. 2013. N 3(2). P. 119-124.

75.     Raythatha, Avani B. S., Shah A., Tucci V.,  Moukaddam N. Synthetic Cannabinoids and Dysphonia: A Case Report. J Gen Practice. 2016. N 4. P. 1.

76.     Redfern A., Sampson C., Giovannelli M. Acute cardiomyopathy with MCAT abuse. Journal of the Intensive Care Society. 2015.  V. 16. N 1. P. 83–84.

77.     Riederer A. M., Campleman S. L., Carlson R. G., Boyer E. W., Manini A. F., Wax P. M., Brent J. A. Toxicology Investigators Consortium (ToxIC). Toxicology Investigators Consortium Registry Sites, 2010-2015. Acute Poisonings from Synthetic Cannabinoids - 50 U.S. MMWR Morb Mortal Wkly Rep. 2016. N 65(27). P. 692-695.

78.     Roberto A. J., Lorenzo A., Li K. J., Young J., Mohan A., Pinnaka S., Lapidus K. First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and Risperidone. A. Case Rep Psychiatry. 2016. 7257489.

79.     Rose D.Z., Guerrero W.R., Mokin M.V., Gooch C. L., Bozeman A.C., Pearson J.M., Burgin W.S. Hemorrhagic stroke following use of the synthetic marijuana "spice". Neurology. 2015. N 85(13). P. 1177-1179.

80.     Samaan J., Ferrer G. F., Akinyemi B., Junquera P.,  Oms J., Dumenigo R. Synthetic Cannabis Overdose and Withdrawal in a Young Adult: A Case Report, Commentary on Regulation, and Review of the Literature. Case Reports in Psychiatry. 2016. V. 2016. P. 7.

81.     Sethi R., Thapa N.,  Saxena A., Chahil R. "K2/Spice": have you updated your differentials? A case report. Prim Care Companion CNS Disord. 2013. N 15(2). pii: PCC.12l01402.

82.     Shanks K. G., Clark W., Behonick G. Death Associated With the Use of the Synthetic Cannabinoid ADB-FUBINACA. J Anal Toxicol. 2016. N 40(3). P. 236-239.

83.     Shanks K. G., Dahn T., Terrell A. R. Detection of JWH-018 and JWH-073 by UPLC-MS-MS in postmortem whole blood casework. J Anal Toxicol. 2012. N 36(3). P. 145-152.

84.     Sharma T. R., Iskandar J. W., Ali R., Shah U. R. Bath salts-induced delirium and brief psychotic episode in an otherwise healthy young man. Prim Care Companion CNS Disord. 2012. N 14(2). pii: PCC.11l01224.

85.     Sheikh I. A., Lukšič M., Ferstenberg R., Culpepper-Morgan J. A. Spice/K2 synthetic marijuana-induced toxic hepatitis treated with N-acetylcysteine. Am J Case Rep. 2014 Dec 30;15:584-8.

86.     Sivagnanam K., Chaudari  D., Lopez P.,  Sutherland M. E., Ramu  V. K. “Bath salts” induced severe reversible cardiomyopathy. Am J Case Rep. 2013. N 14. P. 288–291.

87.     Sönmez I., KÖŞGER  F. Psychotic Disorder Associated With Synthetic Cannabinoid Receptor Agonist: a Case Report. Turkish Journal of Psychiatry.  2014.  N 2014. P.1-2.

88.     Srisung W., Jamal F., Prabhakar S. Synthetic cannabinoids and acute kidney injury. Proc Bayl Univ Med Cent. 2015. N 28(4). P. 475-477.

89.     Streur W. J., Hurlburt W. B., McLaughlin J., Castrodale L. Psychoactive “Bath Salts” Toxicity in Alaska—A Case Series. State of Alaska Epidemioilogy Bulletin. 2011. N 27. Available at: http://www.epi.hss.state.ak.us/bulletins/docs/b2011_27.pdf - (accessed: 03.02.2018).

90.     Truscott S. M., Crittenden N.E., Shaw M.A., Middleberg R.A., Jortani S.A. Violent Behavior and Hallucination in a 32-Year-Old Patient. Clinical Chemistry. V. 59. N 4. P. 612-614.

91.     Ukaigwe A., Karmacharya P., Donato A. A Gut Gone to Pot: A Case of Cannabinoid Hyperemesis Syndrome due to K2, a Synthetic Cannabinoid. Case Rep Emerg Med. 2014. 167098.

92.     United Nations Office on Drugs and Crime (UNODC) Central Asia Synthetic Drugs Situation Assessment - A Report from the UNODC Global SMART Programme Vienna.  December 2017 – P.22-24 – Available at: http://www.unodc.org/documents/scientific/Central_Asia_November_2017_FINAL.pdf - (accessed: 03.02.2018).

93.     UNODC. The challenge of new psychoactive substances. Global SMART Programme. Vienna – 2013. - P. 1.

94.     Vallersnes O. M., Dines A. M., Wood D. M., Yates C., Heyerdahl F., Hovda K. E., Giraudon I. Euro-DEN Research Group, Dargan P. I. Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry. 2016. N 16. P. 293.

95.     Van Amsterdam J., Brunt T., van den Brink W. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects. J Psychopharmacol. 2015. N 29. P. 254–263.

96.     Vorce S. P., Knittel J. L., Holler J. M., Magluilo J. Jr., Levine B., Berran P., Bosy T. Z. A fatality involving AH-7921. J Anal Toxicol. 2014. N 38(4). P. 226-230.

97.     Wyman J. F., Lavins E. S., Engelhart D., Armstrong E. J., Snell K. D., Boggs P. D., Taylor S. M., Norris R. N., Miller F. P. Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts". J Anal Toxicol. 2013. N 37(3). N 182-185.

98.     Yasuhisa Y.F., Koeda F. A., Inoue Y. Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones. Acute Medicine and Surgery. 2016. V. 3. N. 3. P. 230–236.

99.     Yazici A.B., Yazici E., Erol A. Delirium and High Creatine Kinase and Myoglobin Levels Related to Synthetic Cannabinoid Withdrawal. Case Reports in Medicine. 2017. V. 2017. P 6.

100. Zhao A., Tan M., Maung A., Salifu M., Mallappallil M. Rhabdomyolysis and Acute Kidney Injury Requiring Dialysis as a Result of Concomitant Use of Atypical Neuroleptics and Synthetic Cannabinoids. Case Reports in Nephrology. V. 2015. P. 4.



Number of Views: 1088


Bibliography link

Прилуцкая М.В., Молчанов С.Н. Острые эффекты новых психоактивных веществ в клинической практике. Обзор литературы / / Наука и Здравоохранение. 2018. №1. С. 131-152.

Prilutskaya M. V., Molchanov S. N. Acute effects of novel psychoactive substances in clinical practice: a literature review. Nauka i Zdravookhranenie [Science & Healthcare]. 2018, 1, pp. 131-152.

Прилуцкая М.В., Молчанов С.Н. Клиникалық тәжірибеде жаңа психобелсеңді заттардың өткір әсерлері. Әдебиеттік шолу / / Ғылым және Денсаулық сақтау. 2018. № 1. Б. 131-152.


Авторизируйтесь для отправки комментариев